Finance

Lists
ZJYL:NASDAQ
Jin Medical International Ltd
USD 1,96
-1,75%
(-0,035) 1D
2 Okt., 09:50:16 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZJYL...
Open
USD 1,97
High
USD 1,97
Low
USD 1,96
Mkt. cap
154,12 m
Avg. vol.
103,20 k
Volume
1,23 k
P/E ratio
12,91
52-wk high
USD 12,00
52-wk low
USD 1,53
EPS
USD 0,15
Beta
7,41
Shares outstanding
153,42 m
No. of employees
295
Open
USD 1,97
High
USD 1,97
Low
USD 1,96
Mkt. cap
154,12 m
Avg. vol.
103,20 k
Volume
1,23 k
P/E ratio
12,91
52-wk high
USD 12,00
52-wk low
USD 1,53
EPS
USD 0,15
Beta
7,41
Shares outstanding
153,42 m
No. of employees
295
News stories
From web sources and news partners
About Jin Medical International Ltd
CEO-
Employees295
Founded2006
Headquarters-
SectorMedical device
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
5,40 m
5,40 m
4,46 m
4,46 m
Cost of goods sold
3,55 m
3,55 m
3,23 m
3,23 m
Cost of revenue
3,55 m
3,55 m
3,23 m
3,23 m
Research and development expenses
448,41 k
448,41 k
440,86 k
440,86 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
841,40 k
841,40 k
1,08 m
1,08 m
Operating expense
1,32 m
1,32 m
1,55 m
1,55 m
Total operating expenses
4,87 m
4,87 m
4,78 m
4,78 m
Operating income
531,20 k
531,20 k
-322,23 k
-322,23 k
Other non operating income
26,56 k
26,56 k
272,00 k
272,00 k
EBT including unusual items
783,63 k
783,63 k
-152,52 k
-152,52 k
EBT excluding unusual items
783,63 k
783,63 k
-152,52 k
-152,52 k
Income tax expense
97,50 k
97,50 k
-48,02 k
-48,02 k
Effective tax rate
12,44%
12,44%
31,48%
31,48%
Other operating expenses
33,88 k
33,88 k
31,69 k
31,69 k
Net income
640,15 k
640,15 k
-53,87 k
-53,87 k
Net profit margin
11,85%
11,85%
-1,21%
-1,21%
Earnings per share
-
-
-
-
Interest and investment income
243,77 k
243,77 k
19,20 k
19,20 k
Interest expense
-
-
-
-
Net interest expenses
243,77 k
243,77 k
19,20 k
19,20 k
Depreciation and amortization charges
-
-
-
-
EBITDA
587,27 k
587,27 k
-258,59 k
-258,59 k
Gain or loss from assets sale
18,35 k
18,35 k
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme